Catalyst Wire Dossier Catalyst Wire Dossier

Propionyl-L-Carnitine Hydrochloride

Propionyl-L-carnitine hydrochloride · Sigma-Tau i.f.r. S.p.A.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Propionyl-L-Carnitine Hydrochloride, covering 2016-11-07 to 2016-11-07. Get the full timeline:

Most recent: Clinical Trial Update: Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study [Phase 3]

See pricing